Company Monitoring Page for Eisai

latest headlines for company on cafepharma

Gilead’s Kite taps Eisai cancer vet Amoroso to lead the charge for CAR-T sales
Fierce Pharma
Tue, 07/10/18 - 11:29 am
Tags:
Gilead Sciences, CAR-T, Eisai
The Biogen Bump Bodes Well for Biotech
Barron's
Sat, 07/7/18 - 04:32 pm
Tags:
Biogen, Eisai, Alzheimer's disease, BAN2401
Eisai is building a bespoke Cambridge research center with a $100M-plus plan to find new ways to tackle Alzheimer’s
Endpoints
Wed, 06/13/18 - 09:37 am
Tags:
Eisai, R&D, Cambridge MA, Alzheimer's disease
Eisai, Purdue reveal eye-opening data for sleep drug lemborexant
Fierce Biotech
Wed, 06/6/18 - 09:38 am
Tags:
Eisai, Purdue Pharma, lemborexant, sleep disorders, clinical trials, insomnia
ASCO: Merck and its new multibillion-dollar partners hone plans for marketing onslaught
Fierce Pharma
Mon, 06/4/18 - 12:09 pm
Tags:
Merck, ASCO 2018, Keytruda, AstraZeneca, Eisai
FDA stalls Eisai—and its new partner Merck—in quest to widen cancer med Lenvima's reach
Fierce Pharma
Fri, 05/25/18 - 12:15 pm
Tags:
Merck, Eisai, Lenvima, liver cancer, FDA
Eisai Submits Supplemental New Drug Application (sNDA) to FDA for FYCOMPA (perampanel) Pediatric Indications
CP Wire
Mon, 04/2/18 - 03:03 pm
Tags:
Eisai, FDA, Fycompa, pediatric, seizures
Mon, 04/2/18 - 12:31 am
Tags:
Fycompa, Eisai, pediatric epilepsy
Eisai partners with Nichi-Iko in generics pact
Biopharma Dive
Sat, 03/31/18 - 10:02 am
Tags:
Eisai, Nichi-Iko, generics
Doubling down on the Keytruda franchise, Merck pays $300M and promises $5B-plus to partner with Eisai on its budding cancer star
Endpoints
Thu, 03/8/18 - 09:42 am
Tags:
Merck, Keytruda, Eisai, Lenvima
Merck & Co. and Eisai seek to undermine BMS’ position in kidney cancer treatment sector
GoinPharma
Wed, 01/17/18 - 10:05 am
Tags:
Eisai, Merck, Bristol-Myers Squibb, kidney cancer, Keytruda, Lenvima, Opdivo
Merck, Eisai nab Keytruda-Lenvima 'breakthrough' in quickly crowding kidney cancer field
Fierce Pharma
Fri, 01/12/18 - 06:39 pm
Tags:
Merck, Eisai, Keytruda, Lenvima, kidney cancer
Looking for an early success in PhII Alzheimer’s study, Biogen and Eisai just racked up the latest setback
Endpoints
Thu, 12/21/17 - 10:26 am
Tags:
Biogen, Eisai, clinical trials, Alzheimer's disease, BAN2401
Eisai tracking device keeps tabs on out-and-about dementia patients
Fierce Pharma
Wed, 11/29/17 - 10:04 am
Tags:
Eisai, dementia, Mamorio, devices, Me-Mamorio, Alzheimer's disease
Eisai shows confidence in Biogen's Alzheimer's drug
Biopharma Dive
Mon, 10/23/17 - 09:49 pm
Tags:
Eisai, Biogen, Alzheimer's disease, aducanumab
Upstart women’s oncology company in-licenses PhII PARP; Beijing biotech grabs $29M startup round
Endpoints
Fri, 07/7/17 - 10:18 am
Tags:
oncology, PARP inhibitors, 2X Oncology, Eisai, 2X-121, Jazz Pharmaceuticals
Eisai's Lenvima nabs survival edge in liver cancer showdown with Bayer's Nexavar
Fierce Pharma
Sun, 06/4/17 - 11:49 am
Tags:
Eisai, Lenvima, liver cancer, Bayer, Nexavar, ASCO 2017
Eisai extends CRO partnership for malaria drug discovery
BioPharma Dive
Thu, 06/1/17 - 02:47 pm
Tags:
Eisai, CRO, drug development, malaria
Arena Turns Page On Belviq - Restructures Deal With Eisai
Seeking Alpha
Thu, 01/5/17 - 09:15 am
Tags:
Arena Pharmaceuticals, Belviq, Eisai
Eisai latest cancer drugmaker to win UK approval after price cut
Yahoo/Reuters
Thu, 11/3/16 - 09:29 am
Tags:
Eisai, Halaven, UK

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.